AME Ametek
Superb niche compounder, but the market prices acquisitions as if they were free; still well overvalued.
The story
Ametek is a decentralized collection of niche electronic instruments and electromechanical businesses. It holds leading shares in small, mission-critical markets where it has pricing power, and it adds growth through a disciplined bolt-on acquisition program. The business is a mature compounder: margins are steady around 25-26%, organic growth runs mid-single digits, and acquisitions add a few more points. Each acquired dollar of growth is costly in capital because it carries goodwill.
I kept growth at 7%, beta at 1.0 and failure risk at 1%: TTM growth of about 6% plus acquisitions supports 7%. The margin moves slightly up to 26% because the business sustains 25-26% margins through the cycle. I raised sales-to-capital from 0.6 to 0.8 (+33%) because the 0.6 figure blends goodwill-heavy acquisitions with capital-light organic growth (capex is under 2% of sales). The old value was also about 65% below a heavily covered price, which pushed me to revisit this driver. A 10-year horizon reflects a durable but niche-bounded moat.
Value drivers
| Revenue growth (Y1) | 7.0% |
| Terminal growth | 3.0% |
| Forecast horizon | 10y |
| Target operating margin | 26.0% |
| Years to target margin | 5 |
| Sales-to-capital | 0.80 |
| Beta | 1.00 |
| Failure probability | 1.0% |
| Cost of capital (WACC) | 9.6% |
| Terminal WACC | 9.6% |
Valuation bridge
| PV of explicit FCFF | 9.84B |
| PV of terminal value | 13.04B |
| Equity value | 20.85B |
| ÷ shares → per share | $90.93 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 8.41B | 7.0% | 25.6% | 1.77B | 688.09M | 1.08B | 988.71M |
| 2 | 8.97B | 6.6% | 25.7% | 1.90B | 689.51M | 1.21B | 1.00B |
| 3 | 9.51B | 6.1% | 25.8% | 2.02B | 684.90M | 1.33B | 1.01B |
| 4 | 10.05B | 5.7% | 25.9% | 2.14B | 673.90M | 1.47B | 1.02B |
| 5 | 10.58B | 5.2% | 26.0% | 2.26B | 656.24M | 1.61B | 1.02B |
| 6 | 11.08B | 4.8% | 26.0% | 2.37B | 631.74M | 1.74B | 1.00B |
| 7 | 11.56B | 4.3% | 26.0% | 2.47B | 600.35M | 1.87B | 985.96M |
| 8 | 12.01B | 3.9% | 26.0% | 2.57B | 562.13M | 2.01B | 964.05M |
| 9 | 12.43B | 3.4% | 26.0% | 2.66B | 517.24M | 2.14B | 937.95M |
| 10 | 12.80B | 3.0% | 26.0% | 2.74B | 466.02M | 2.27B | 908.04M |
Key risks
- Acquisition overpayment or slowing deal flow eroding growth and returns on capital
- Industrial and semiconductor cycle downturn compressing organic growth and margins
- Multiple compression from a premium valuation if growth slips to low single digits
Catalysts
- Large accretive acquisition deployed at high returns
- Organic growth reacceleration with operating-margin expansion above 26%